ADIM
Alpha DNA Investment Management Portfolio holdings
AUM
$5.25M
1-Year Return
16.75%
This Quarter Return
+13.61%
1 Year Return
+16.75%
3 Year Return
+76.55%
5 Year Return
–
10 Year Return
–
AUM
$87M
AUM Growth
-$6.82M
(-7.3%)
Cap. Flow
-$1.88M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
19.17%
Holding
838
New
190
Increased
180
Reduced
205
Closed
92
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.84M |
| 2 |
SENT
AdvisorShares Alpha DNA Equity Sentiment ETF
SENT
|
+$1.41M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.23M |
| 4 |
Intel
INTC
|
+$970K |
| 5 |
Bath & Body Works
BBWI
|
+$936K |
Top Sells
| 1 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$1.88M |
| 2 |
Sleep Number
SNBR
|
+$1.27M |
| 3 |
Texas Instruments
TXN
|
+$1.15M |
| 4 |
NXP Semiconductors
NXPI
|
+$1.14M |
| 5 |
Lowe's Companies
LOW
|
+$1.12M |
Sector Composition
| 1 | Technology | 44.1% |
| 2 | Consumer Discretionary | 19.26% |
| 3 | Financials | 4.57% |
| 4 | Healthcare | 4.2% |
| 5 | Communication Services | 3.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Blackstone
BX
$135B
| $2K | ﹤0.01% |
34
| – | – |
|
552
Boyd Gaming
BYD
$6.84B
| $2K | ﹤0.01% |
40
-101
| -72% | -$5.05K |
|
553
CarGurus
CARG
$3.56B
| $2K | ﹤0.01% |
113
-25,598
| -100% | -$453K |
|
554
Cardlytics
CDLX
$52.2M
| $2K | ﹤0.01% |
+27
| New | +$2K |
|
555
Chegg
CHGG
$168M
| $2K | ﹤0.01% |
44
+35
| +389% | +$1.59K |
|
556
Chewy
CHWY
$17.4B
| $2K | ﹤0.01% |
27
| – | – |
|
557
Corteva
CTVA
$49.2B
| $2K | ﹤0.01% |
64
| – | – |
|
558
Camping World
CWH
$1.12B
| $2K | ﹤0.01% |
80
| – | – |
|
559
Deere & Co
DE
$129B
| $2K | ﹤0.01% |
+8
| New | +$2K |
|
560
Digital Realty Trust
DLR
$55.9B
| $2K | ﹤0.01% |
16
| – | – |
|
561
EXL Service
EXLS
$7.13B
| $2K | ﹤0.01% |
135
| – | – |
|
562
Fortune Brands Innovations
FBIN
$7.05B
| $2K | ﹤0.01% |
+36
| New | +$2K |
|
563
F5
FFIV
$18.7B
| $2K | ﹤0.01% |
16
-2,721
| -99% | -$340K |
|
564
Fifth Third Bancorp
FITB
$30.1B
| $2K | ﹤0.01% |
59
| – | – |
|
565
Fulgent Genetics
FLGT
$683M
| $2K | ﹤0.01% |
+31
| New | +$2K |
|
566
Howard Hughes
HHH
$4.64B
| $2K | ﹤0.01% |
33
-81
| -71% | -$4.91K |
|
|
HIMX
567
Himax Technologies
HIMX
$1.46B
| $2K | ﹤0.01% |
157
-597
| -79% | -$7.61K |
|
568
Jazz Pharmaceuticals
JAZZ
$7.8B
| $2K | ﹤0.01% |
15
| – | – |
|
569
Masco
MAS
$15.4B
| $2K | ﹤0.01% |
50
-101
| -67% | -$4.04K |
|
570
Medtronic
MDT
$121B
| $2K | ﹤0.01% |
19
| – | – |
|
571
Medifast
MED
$152M
| $2K | ﹤0.01% |
13
| – | – |
|
572
Ocular Therapeutix
OCUL
$2.22B
| $2K | ﹤0.01% |
127
+45
| +55% | +$709 |
|
573
Organogenesis Holdings
ORGO
$620M
| $2K | ﹤0.01% |
+163
| New | +$2K |
|
574
PAR Technology
PAR
$1.9B
| $2K | ﹤0.01% |
43
+19
| +79% | +$884 |
|
575
Penumbra
PEN
$11.2B
| $2K | ﹤0.01% |
+11
| New | +$2K |
|